IPO registrations (S-1, F-1) · Registrants
Z Squared Inc.
- SEC CIK
- 1759186 · filings on EDGAR ↗
- Former names
- Coeptis Therapeutics Holdings, Inc. (2022–2026); Bull Horn Holdings Corp. (2019–2022)
- Registration
- Form S-1, first filed 2020-09-21, last 2026-06-26; 6 initial registrations, 10 amendments
- Outcome
- Final prospectus filed 2020-11-02; declared effective 2020-10-27
- Industry (SIC)
- Finance Services 6199
- Incorporated in
- DE
- Business address
- 550 SOUTH ANDREWS AVE., STE #700, Fort Lauderdale, FL 33301
- EIN
- 98-1465952
- Ticker
- ZSQR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Z Squared Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2020-11-02, an initial public offering)
- Shares sold
- 7,500,000
- Gross proceeds
- $75,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BHSE
- Lead underwriters
- Imperial Capital
- Syndicate
- I -Bankers Securities, Inc; Northland Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Z SQUARED, INC. Fuzzy (name and state)
- Business registration: Z SQUARED, LLC Fuzzy (name and state)
- Form D issuer: Coeptis Therapeutics Holdings, Inc. EXACT (CIK (EXACT))
- SEC filer: Bull Horn Holdings Corp. EXACT (CIK (EXACT))
Filings 30
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-09-21 | S-1 | S-1 (registration) | Bull Horn Holdings Corp. | 0001213900-20-027555 ↗ |
| 2020-10-09 | S-1/A | S-1/A (amendment) | Bull Horn Holdings Corp. | 0001213900-20-030696 ↗ |
| 2020-10-13 | S-1/A | S-1/A (amendment) | Bull Horn Holdings Corp. | 0001213900-20-030971 ↗ |
| 2020-10-22 | S-1/A | S-1/A (amendment) | Bull Horn Holdings Corp. | 0001213900-20-032690 ↗ |
| 2020-10-26 | S-1/A | S-1/A (amendment) | Bull Horn Holdings Corp. | 0001213900-20-033271 ↗ |
| 2020-10-27 | EFFECT | EFFECT (declared effective) | Bull Horn Holdings Corp. | 9999999995-20-002994 ↗ |
| 2020-10-29 | EFFECT | EFFECT (declared effective) | Bull Horn Holdings Corp. | 9999999995-20-003025 ↗ |
| 2020-11-02 | 424B4 | 424B4 (final prospectus) | Bull Horn Holdings Corp. | 0001213900-20-034411 ↗ |
| 2022-09-30 | EFFECT | EFFECT (declared effective) | Bull Horn Holdings Corp. | 9999999995-22-002875 ↗ |
| 2023-02-14 | S-1 | S-1 (registration) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-000853 ↗ |
| 2023-04-27 | S-1/A | S-1/A (amendment) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-002662 ↗ |
| 2023-05-31 | S-1/A | S-1/A (amendment) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-003765 ↗ |
| 2023-06-07 | S-1/A | S-1/A (amendment) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-003960 ↗ |
| 2023-06-13 | S-1/A | S-1/A (amendment) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-004085 ↗ |
| 2023-06-13 | S-1MEF | S-1MEF (added securities) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-004106 ↗ |
| 2023-06-13 | EFFECT | EFFECT (declared effective) | Coeptis Therapeutics Holdings, Inc. | 9999999995-23-001733 ↗ |
| 2023-06-14 | S-1MEF | S-1MEF (added securities) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-004108 ↗ |
| 2023-06-15 | 424B4 | 424B4 (final prospectus) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-004156 ↗ |
| 2023-11-15 | S-1 | S-1 (registration) | Coeptis Therapeutics Holdings, Inc. | 0001683168-23-008149 ↗ |
| 2023-11-29 | EFFECT | EFFECT (declared effective) | Coeptis Therapeutics Holdings, Inc. | 9999999995-23-003490 ↗ |
| 2025-01-10 | S-1 | S-1 (registration) | Coeptis Therapeutics Holdings, Inc. | 0001683168-25-000229 ↗ |
| 2025-02-07 | S-1/A | S-1/A (amendment) | Coeptis Therapeutics Holdings, Inc. | 0001683168-25-000839 ↗ |
| 2025-04-04 | S-1/A | S-1/A (amendment) | Coeptis Therapeutics Holdings, Inc. | 0001683168-25-002278 ↗ |
| 2025-04-21 | EFFECT | EFFECT (declared effective) | Coeptis Therapeutics Holdings, Inc. | 9999999995-25-001159 ↗ |
| 2025-04-23 | 424B4 | 424B4 (final prospectus) | Coeptis Therapeutics Holdings, Inc. | 0001683168-25-002761 ↗ |
| 2025-12-23 | EFFECT | EFFECT (declared effective) | Coeptis Therapeutics Holdings, Inc. | 9999999995-25-003895 ↗ |
| 2026-06-09 | S-1 | S-1 (registration) | Z Squared Inc. | 0001185185-26-002439 ↗ |
| 2026-06-16 | EFFECT | EFFECT (declared effective) | Z Squared Inc. | 9999999995-26-002026 ↗ |
| 2026-06-22 | EFFECT | EFFECT (declared effective) | Z Squared Inc. | 9999999995-26-002074 ↗ |
| 2026-06-26 | S-1 | S-1 (registration) | Z Squared Inc. | 0001185185-26-002685 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-10-26 | S-1/A | registration statement | $10.00 | 7,500,000 | $75,000,000 | Nasdaq BHSE | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ | |
| 2020-11-02 | 424B4 | final prospectus | $10.00 | 7,500,000 | $75,000,000 | Nasdaq BHSE | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bull Horn Holdings Sponsor LLC | TenPercentOwner | 3 | 2020–2022 | ||
| Calise Chris | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Financial Officer | 7 | 2020–2026 | |
| Davis Baron | Director | 1 | 2020 | ||
| Gandler Michael Milton | Director | 1 | 2020 | ||
| Masters Stephen | Director | 1 | 2020 | ||
| Schaer Douglas D | Director | 1 | 2020 | ||
| Striar Robert | Director,Officer,TenPercentOwner; TenPercentOwner | CEO; Chief Executive Officer | 4 | 2020–2022 | |
| Wattenburg Jeffrey | Director | 1 | 2020 | ||
| GLAZER CAPITAL, LLC | TenPercentOwner | 2 | 2020–2021 | ||
| GLAZER PAUL J | TenPercentOwner | 2 | 2020–2021 | ||
| BARCLAYS PLC | TenPercentOwner | 2 | 2021 | ||
| Fortmiller Frederick Vincent Jr. | TenPercentOwner | 2 | 2022 | ||
| Harraden Circle Investments, LLC | TenPercentOwner | 2 | 2022 | ||
| Harraden Circle Investors GP, LLC | TenPercentOwner | 2 | 2022 | ||
| Harraden Circle Investors GP, LP | TenPercentOwner | 2 | 2022 | ||
| Harraden Circle Investors, LP | TenPercentOwner | 2 | 2022 | ||
| Cochran Christopher P. | Director | 5 | 2022–2026 | ||
| Deschamps Philippe | Director | 4 | 2022–2026 | ||
| DeSilva Tara | Director | 5 | 2022–2026 | ||
| Mehalick David | Director,Officer,TenPercentOwner | CEO and President | 6 | 2022–2026 | |
| Salkind Gene | Director | 6 | 2022–2026 | ||
| Sheehy Christine Elise | Director,Officer; Officer | CFO and Secretary; VP Compliance and Secy | 4 | 2022–2026 | |
| Yerace Daniel Alexander | Director,Officer | VP of Operations; VP Operations | 5 | 2022–2026 | |
| Cogley Brian | Officer | Chief Financial Officer | 5 | 2024–2026 | |
| Burke Michelle Ellen | Director,Officer | Co-Chief Executive Officer | 2 | 2026 | |
| Cooper Kenneth Lyle | Director | 2 | 2026 | ||
| Fuerst Bryan Eric | Director | 2 | 2026 | ||
| Halabu David Elias | Director,Officer | Co-Chief Executive Officer | 2 | 2026 | |
| Schadel Christopher Ryan | Officer | Chief Marketing Officer | 4 | 2026 | |
| Sohn Adam Craig | Director | 2 | 2026 | ||
| BSG Series CM, LLC | TenPercentOwner | 2 | 2026 | ||
| Harris Jeffery Keeslar | Officer | Chief Technology Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-08-07 | Coeptis Therapeutics Holdings, Inc. | Pharmaceuticals | $5,000,000 | $4,000,000 | 9 | 1 |
| 2024-06-27 | Coeptis Therapeutics Holdings, Inc. | Pharmaceuticals | $10,000,000 | $4,300,000 | 7 | 1 |
| 2023-11-03 | Coeptis Therapeutics Holdings, Inc. | Pharmaceuticals | $2,000,000 | $2,000,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Z SQUARED, INC. | FL | State business registries | name and state |
| Business registration | Z SQUARED, LLC | FL | State business registries | name and state |
| Form D issuer | Coeptis Therapeutics Holdings, Inc. | PA | Form D private offerings | CIK (EXACT) |
| SEC filer | Z Squared Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Finance Services, FL first:
- MGT CAPITAL INVESTMENTS, INC. FL
- STERLING FINANCIAL SERVICES OF FLORIDA I INC FL
- Athena Bitcoin Global FL
- SBS FUNDING INC FL
- Tron Inc. FL
- OpenWorld, Inc. FL
- NextPlay Technologies Inc. FL
- Stablecoin Development Corp FL
- T-REX Acquisition Corp. FL
- AXE COMPUTE INC. FL
In other datasets, the same topic (Finance) in FL:
- Form D issuer: Aeterna Opes NH Fund I LP (Form D private offerings)
- Lobbying client: 777 PARTNERS LLC (Federal lobbying (LDA))
Interests: Finance Services · Finance